ArriVent Biopharma, Inc. Contracts & Agreements

25 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
ArriVent BioPharma, Inc. Pre-Funded Warrant to Purchase Common Stock Agreement
Warrant Agreements
ArriVent Biopharma, Inc.
2025
Underwriting Agreement between ArriVent BioPharma, Inc. and Underwriters for Common Stock and Pre-Funded Warrants Offering
Underwriting Agreements
ArriVent Biopharma, Inc.
2025
ArriVent BioPharma, Inc. Amended and Restated Non-Employee Director Compensation Policy (March 20, 2025)
Compensation Agreements
ArriVent Biopharma, Inc.
2025
Exclusive License Agreement between Lepu Biopharma Co., Ltd. and ArriVent Biopharma, Inc. (MRG007 Antibody-Drug-Conjugate)
License Agreements
ArriVent Biopharma, Inc.
2025
Amended and Restated Research Collaboration Agreement between Aarvik Therapeutics, Inc. and ArriVent BioPharma, Inc.
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Research and Collaboration Agreement between Jiangsu Alphamab Biopharmaceuticals Co., Ltd and ArriVent BioPharma, Inc. (June 2, 2024)
Collaboration Agreements
ArriVent Biopharma, Inc.
NY
2024
Description of ArriVent Biopharma, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
ArriVent Biopharma, Inc.
2024
ArriVent Biopharma, Inc. Executive Severance Plan
Severance Agreements
ArriVent Biopharma, Inc.
DE
2024
ArriVent Biopharma, Inc. 2024 Employee, Director and Consultant Equity Incentive Plan
Bonus & Incentive Agreements
ArriVent Biopharma, Inc.
DE
2024
ArriVent BioPharma, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Jefferies, and Citigroup (2024)
Underwriting Agreements
ArriVent Biopharma, Inc.
2024
Joint Clinical Collaboration Agreement between Shanghai Allist Pharmaceuticals Co., Ltd. and ArriVent BioPharma, Inc.
Collaboration Agreements
ArriVent Biopharma, Inc.
2024
Clinical Collaboration Agreement between ArriVent BioPharma Inc. and Beijing InnoCare Pharma Tech Co., Ltd. (June 23, 2023)
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Research Collaboration Agreement between Aarvik Therapeutics, Inc. and ArriVent Biopharma, Inc.
Collaboration Agreements
ArriVent Biopharma, Inc.
CA
2024
Amended and Restated Investors’ Rights Agreement by and among ArriVent BioPharma, Inc. and Investors (December 16, 2022)
Investor Rights Agreements
ArriVent Biopharma, Inc.
DE
2024
Global Technology Transfer and License Agreement between ArriVent Biopharma, Inc. and Shanghai Allist Pharmaceuticals Co., Ltd.
License Agreements
ArriVent Biopharma, Inc.
DE
2024
ArriVent Biopharma, Inc. Employment Offer Letter to Winston Kung as Chief Financial Officer & Treasurer
Employment Agreements
ArriVent Biopharma, Inc.
2024
ArriVent Biopharma, Inc. Employment Offer Letter to Jim Kastenmayer (General Counsel)
Employment Agreements
ArriVent Biopharma, Inc.
2024
ArriVent Biopharma, Inc. Employment Offer Letter to Robin LaChapelle (Chief Administrative Officer and Co-Founder)
Employment Agreements
ArriVent Biopharma, Inc.
2024
ArriVent Biopharma, Inc. Employment Offer Letter to Stuart Lutzker (Chief Medical Officer and Co-Founder)
Employment Agreements
ArriVent Biopharma, Inc.
2024
ArriVent Biopharma, Inc. Employment Offer Letter to Bing Yao (Chief Executive Officer and Founder)
Employment Agreements
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Clawback Policy for Executive Compensation
Compensation Agreements
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Non-Employee Director Compensation Policy (2023)
Compensation Agreements
ArriVent Biopharma, Inc.
2024
ArriVent BioPharma, Inc. Executive Severance Plan
Severance Agreements
ArriVent Biopharma, Inc.
DE
2024
ArriVent Biopharma, Inc. 2021 Employee, Director and Consultant Equity Incentive Plan
Bonus & Incentive Agreements
ArriVent Biopharma, Inc.
DE
2024
Indemnification Agreement between ArriVent BioPharma, Inc. and Indemnitee
Indemnification Agreements
ArriVent Biopharma, Inc.
DE
2024